Doxefazepam

DB13837ExperimentalSmall molecule

Doxefazepam: Overview.

Mechanism: Pharmacologically active on GABA(A) Receptor and GABA(A) Receptor Benzodiazepine Binding Site
Curator reviewed
Formula / weight: C₁₇H₁₄ClFN₂O₃ · 348.756 g/mol (avg)
Code names: BRN 0767530 · SAS-643

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyVOJLELRQLPENHL-UHFFFAOYSA-NSMILESOCCN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1F

What you can answer from here — as of February 21, 2021

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

716Drug interactionsStructured to mechanism, not free text

3Marketed productsAcross 1 country and 1 labeller

1ATC codeIncluding every combination product, plus 8 drug categories

4+ReferencesStructured and connected to the statements they support

Which companies are running trials of Doxefazepam, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.